BONE MINERAL DENSITY--INFLUENCE OF AGE AND RACE

骨矿物质密度——年龄和种族的影响

基本信息

  • 批准号:
    6121396
  • 负责人:
  • 金额:
    $ 6.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-12-01 至 1999-11-30
  • 项目状态:
    已结题

项目摘要

Bone mass decreases with increasing age in both men and women. Factors that influence the rate of bone loss include age and gender, as well as race. Bone loss in African American men and women is slower than in Caucasian men and women. Bone density scans, which have become the "gold standard" for measuring bone loss, have not adequately addressed gender- based differences in osteopenia in an aging population. Furthermore, the comparison of African American bone loss rates with those of Caucasians has not received adequate study. The goal of this protocol is to correlate bone mineral density (BMD) at two anatomical sites with serum and urine markers of skeletal turnover over a period of 24 months in a population of aging African American and Caucasian men and postmenopausal women. During this reporting period, the final five patients were studied. The results of the entire study indicate that while DEXA scans may be the gold standard for staging bone loss, the urinary marker deoxypyridinoline appears to be the most informative biomarker for dynamic bone loss. The serum markers osteocalcin and procollagen type I carboxyl terminal peptide exhibited a lack of correlation with ethnicity and gender. Because of limited enrollment in this study (70 total), the results lack the power to define statistically meaningful differences between the multiple subgroups stratified by age, gender and ethnicity. The results do confirm previous observations of higher bone mass and reduced rate of bone loss in the African American study population.
男性和女性的骨量随着年龄的增长而减少。影响骨质流失率的因素包括年龄、性别以及种族。非裔美国人的骨质流失比白人男性和女性慢。骨密度扫描,已成为测量的“金标准” 骨丢失,还没有充分解决老龄人口中骨质减少的性别差异。此外,非洲裔美国人与高加索人骨丢失率的比较尚未得到充分的研究。本方案的目的是在24个月的时间内,在一个老龄化的非洲裔美国人和白人男性和绝经后女性人群中,将两个解剖部位的骨矿物质密度(BMD)与骨骼转换的血清和尿液标志物相关联。在本报告期间,对最后5例患者进行了研究。整个研究的结果表明,尽管DEXA扫描可能是骨丢失分期的金标准,但尿标记物脱氧吡啶啉似乎是最重要的。 动态骨丢失的信息性生物标志物。血清标志物骨钙素和I型前胶原羧基末端肽表现出缺乏相关性与种族和性别。由于本研究的入组人数有限(共70人),因此结果无法定义按年龄、性别和种族分层的多个亚组之间的统计学显著差异。结果证实了先前在非裔美国人研究人群中观察到的较高骨量和骨丢失率降低。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY Robert SHAPIRO其他文献

JAY Robert SHAPIRO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY Robert SHAPIRO', 18)}}的其他基金

TERIPARATIDE (FORTEO) FOR INCREASING BONE MASS
用于增加骨量的特立帕肽 (Forteo)
  • 批准号:
    7604687
  • 财政年份:
    2006
  • 资助金额:
    $ 6.52万
  • 项目类别:
GENETICS OF OSTEOPOROSIS IN OLD ORDER AMISH
老阿米什人骨质疏松症的遗传学
  • 批准号:
    6121420
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
EFFECT OF MINOCYCLINE IN POSTMENOPAUSAL OSTEOPOROSIS
米诺环素对绝经后骨质疏松症的作用
  • 批准号:
    6121421
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
SKELETAL TURNOVER IN OSTEOGENESIS IMPERFECTA--EFFECT OF PAMIDRONATE THERAPY
成骨不全症的骨骼转换--帕米膦酸钠治疗的效果
  • 批准号:
    6281935
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
EFFECT OF MINOCYCLINE IN POSTMENOPAUSAL OSTEOPOROSIS
米诺环素对绝经后骨质疏松症的作用
  • 批准号:
    6281961
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
GENETICS OF OSTEOPOROSIS IN OLD ORDER AMISH
老阿米什人骨质疏松症的遗传学
  • 批准号:
    6281960
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
BONE MINERAL DENSITY--INFLUENCE OF AGE AND RACE
骨矿物质密度——年龄和种族的影响
  • 批准号:
    6281936
  • 财政年份:
    1998
  • 资助金额:
    $ 6.52万
  • 项目类别:
CORRELATION OF BMD WITH PARAMETERS OF SKELETAL TURNOVER--INFLUENCE OF AGE & RACE
BMD与骨骼转换参数的相关性——年龄的影响
  • 批准号:
    6252495
  • 财政年份:
    1997
  • 资助金额:
    $ 6.52万
  • 项目类别:
SKELETAL TURNOVER IN OSTEOGENESIS IMPERFECTA--EFFECT OF PAMIDRONATE THERAPY
成骨不全症的骨骼转换--帕米膦酸钠治疗的效果
  • 批准号:
    6252493
  • 财政年份:
    1997
  • 资助金额:
    $ 6.52万
  • 项目类别:
BONE MARROW OSTEOPROGENITOR CELLS IN TYPES I AND II OSTEOPOROSIS
I 型和 II 型骨质疏松症的骨髓骨祖细胞
  • 批准号:
    6252500
  • 财政年份:
    1997
  • 资助金额:
    $ 6.52万
  • 项目类别:

相似海外基金

Linking Social-Behavior Contextual Factors and Allostatic Load to Chronic Diseases in Diverse Asian Americans: A Socioecological Approach to Advancing Precision Medicine and Health Equity
将社会行为背景因素和稳态负荷与不同亚裔美国人的慢性病联系起来:推进精准医疗和健康公平的社会生态学方法
  • 批准号:
    10799170
  • 财政年份:
    2023
  • 资助金额:
    $ 6.52万
  • 项目类别:
Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0
亚裔美国人、夏威夷原住民和太平洋岛民研究与教育 (CARE) 2.0 合作方法
  • 批准号:
    10740342
  • 财政年份:
    2023
  • 资助金额:
    $ 6.52万
  • 项目类别:
Asian Americans & Racism: Individual and Structural Experiences (ARISE)
亚裔美国人
  • 批准号:
    10900989
  • 财政年份:
    2023
  • 资助金额:
    $ 6.52万
  • 项目类别:
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans
研究老年亚裔美国人阿尔茨海默病和阿尔茨海默病相关痴呆症的研究基础设施
  • 批准号:
    10730082
  • 财政年份:
    2023
  • 资助金额:
    $ 6.52万
  • 项目类别:
Elucidating the high and heterogeneous risk of gestational diabetes among Asian Americans: an integrative approach of metabolomics, lifestyles, and social determinants
阐明亚裔美国人妊娠期糖尿病的高且异质性风险:代谢组学、生活方式和社会决定因素的综合方法
  • 批准号:
    10804399
  • 财政年份:
    2023
  • 资助金额:
    $ 6.52万
  • 项目类别:
Disaggregating Asian Americans and Pacific Islanders to identify mechanisms of adolescent suicide risk: The role of school stressors, alcohol, sleep, and school/community contexts
分解亚裔美国人和太平洋岛民,以确定青少年自杀风险的机制:学校压力源、酒精、睡眠和学校/社区环境的作用
  • 批准号:
    10355313
  • 财政年份:
    2022
  • 资助金额:
    $ 6.52万
  • 项目类别:
Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.
努力消除东南亚裔美国人肝癌护理差异:交通和其他健康的社会决定因素。
  • 批准号:
    10710050
  • 财政年份:
    2022
  • 资助金额:
    $ 6.52万
  • 项目类别:
Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.
努力消除东南亚裔美国人肝癌护理差异:交通和其他健康的社会决定因素。
  • 批准号:
    10584157
  • 财政年份:
    2022
  • 资助金额:
    $ 6.52万
  • 项目类别:
Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites
亚裔美国人、夏威夷原住民和白人早期 NAFLD 进展和肠道微生物组的纵向研究
  • 批准号:
    10607981
  • 财政年份:
    2022
  • 资助金额:
    $ 6.52万
  • 项目类别:
Disaggregating Asian Americans and Pacific Islanders to identify mechanisms of adolescent suicide risk: The role of school stressors, alcohol, sleep, and school/community contexts
分解亚裔美国人和太平洋岛民,以确定青少年自杀风险的机制:学校压力源、酒精、睡眠和学校/社区环境的作用
  • 批准号:
    10544534
  • 财政年份:
    2022
  • 资助金额:
    $ 6.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了